Clinical trials
Phase 2 Urogenital Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 9 |
| Unknown status | 7 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| NanOlogy, LLC | 2 |
| Steba Biotech S.A. | 2 |
| The Netherlands Cancer Institute | 2 |
| University of California, Irvine | 2 |
| Xiaoxiang Chen | 2 |
| Alessandro D'Agnolo | 1 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 1 |
| Belgian Gynaecological Oncology Group | 1 |
| Betul Kartal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 37 |
| Neoplasms | 13 |
| Prostatic Neoplasms | 12 |
| Genital Neoplasms, Male | 10 |
| Neoplasms by Site | 10 |
| Ovarian Neoplasms | 10 |
| Carcinoma | 8 |
| Neoplasms, Glandular and Epithelial | 8 |
| Prostatic Diseases | 8 |
| Urologic Neoplasms | 8 |
Trials
Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.